vitamin K antagonists, D-dimer,
Showing 1 - 25 of >10,000
Different Antithrombotic Therapy for Treatment of Ventricular
Recruiting
- Ventricular Thrombus
- non-vitamin K antagonist oral anticoagulants (NOACs)
- +3 more
-
Beijing, ChinaQing Yang
Jul 11, 2022
Obesity, Vitamin D3 Deficiency Trial in Rio de Janeiro (Vitamin D3 + K2-MK7, Placebo, Vitamin D3)
Recruiting
- Obesity
- Vitamin D3 Deficiency
- Vitamin D3 + K2-MK7
- +2 more
-
Rio de Janeiro, BrazilRio de Janeiro State University
Jan 10, 2023
Bone Density, Bone Health, Fractures Trial in Boston (Vitamin D3 , Fish oil , Omega-3 fatty acids (fish oil))
Active, not recruiting
- Bone Density
- +2 more
- Vitamin D3 placebo
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 14, 2022
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
Diabetes Type 2 With Periodontal Disease Trial in Kirikkale (Vitamin D3K2, Saline Solution)
Completed
- Diabetes Mellitus Type 2 With Periodontal Disease
- Vitamin D3K2
- Saline Solution
-
Kırıkkale, TurkeyKirikkale University
Oct 5, 2023
Covid19 Trial in Ottawa (drug, dietary supplement, other)
Suspended
- Covid19
- Vitamin D3 50,000 IU
- +4 more
-
Ottawa, Ontario, CanadaThe Centre for Health Innovation
Aug 8, 2022
Vitamin D Trial in Coquitlam (Vitamin D3)
Recruiting
- Vitamin D
- Vitamin D3
-
Coquitlam, British Columbia, CanadaNatural Factors
Aug 2, 2022
Sub-optimal Vitamin D Status, Bone Disease, Diabetic Nephropathy Trial in Edmonton (Vitamin D3)
Completed
- Sub-optimal Vitamin D Status
- +2 more
- Vitamin D3
-
Edmonton, Alberta, CanadaClinical Research Unit, University of Alberta
Aug 25, 2022
Deep Vein Thrombosis, Pulmonary Embolism Trial in Bologna (Vitamin K antagonist (Coumarin anticoagulants))
Completed
- Deep Vein Thrombosis
- Pulmonary Embolism
- Vitamin K antagonist (Coumarin anticoagulants)
-
Bologna, BO, ItalyDept. of Angiology & Blood Coagulation, University Hospital S. O
Mar 18, 2021
Bleeding From Teeth, Bleeding Prophylaxis Trial in Worldwide (Tranexamic acid)
Recruiting
- Bleeding From Teeth
- Bleeding Prophylaxis
- Tranexamic acid
-
Loma Linda, California
- +18 more
Nov 21, 2023
Post-acute COVID-19 Syndrome Trial in Cleveland (Vitamin K2 (MK-7), Vitamin D3)
Recruiting
- Post-acute COVID-19 Syndrome
- Vitamin K2 (MK-7)
- Vitamin D3
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Jun 9, 2022
Asthma Trial in Canada (Vitamin D, Placebo)
Recruiting
- Asthma
- Vitamin D
- Placebo
-
Vancouver, British Columbia, Canada
- +8 more
Jan 30, 2023
Diabetes Trial in Lahore (Oral Hypoglycemic Agents,Oral, Voreta, Voreta plus SunnyD PRO)
Not yet recruiting
- Diabetes Mellitus
- Oral Hypoglycemic Agents,Oral
- +2 more
-
Lahore, Punjab, PakistanUniversity of Health Sciences
Jun 10, 2022
Atrial Fibrillation, End-stage Kidney Disease Trial in Münster (Apixaban, Phenprocoumon)
Recruiting
- Atrial Fibrillation
- End-stage Kidney Disease
-
Münster, GermanyUniversitätsklinikum Münster
Apr 26, 2021
Gather Information on Kidney Function of Non-valvular Atrial
Completed
- Non-Valvular Atrial Fibrillation
- Rivaroxaban (Xarelto, BAY-597939)
- VKAs
-
Multiple Locations, United KingdomMany locations
Mar 1, 2021
Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound
Not yet recruiting
- Biliary Atresia
- +2 more
- Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
- Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
- (no location specified)
Jun 28, 2023
Aortic Valve Stenosis, Multidetector Computed Tomography, Vitamin K 2 Trial in Odense (Menaquinone-7 720 µg/day including the
Completed
- Aortic Valve Stenosis
- +3 more
- Menaquinone-7 720 µg/day including the recommended daily dose of vitamin D (25 µg/day).
- Placebo
-
Odense, Odense C, DenmarkDepartment of Cardiology, Odense University Hospital
Sep 28, 2022
Renal Insufficiency Trial in France (Apixaban, Rivaroxaban, Heparin)
Active, not recruiting
- Renal Insufficiency
- Apixaban
- +3 more
-
Arras, Boulevard Georges Besnier, France
- +30 more
Feb 2, 2022
The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study
Completed
- Suspected Deep Vein Thrombosis
-
Edmonton, Alberta, Canada
- +9 more
Sep 27, 2021
Kidney Failure, Chronic Trial in France (No oral anticoagulation, Oral anticoagulation with vitamin K antagonists)
Recruiting
- Kidney Failure, Chronic
- No oral anticoagulation
- Oral anticoagulation with vitamin K antagonists
-
Amiens, France
- +24 more
Sep 13, 2021
Anticoagulant-induced Bleeding Trial in Quebec (Warfarin, Dabigatran, Rivaroxaban)
Not yet recruiting
- Anticoagulant-induced Bleeding
- Warfarin
- +4 more
-
Quebec, CanadaInstitut Universitaire de Cardiologie et de Pneumologie de Quebe
Feb 17, 2021
During and After Anticoagulation inPrevious Venous
Completed
- Deep Vein Thrombosis
- Pulmonary Embolism
-
Bologna, BO, ItalyDept. Angiology & Blood Coagulation; Azienda Ospedaliero-Univers
Mar 18, 2021
Coronary Artery Disease, Carotid Artery Disease Trial (MK-7 and vitamin D3, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Carotid Artery Disease
- MK-7 and vitamin D3
- Placebo
- (no location specified)
Feb 11, 2021